Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

At the coalface--medical ethics in practice. First, do no harm

S Groudine1, P D Lumb

  • 1Albany Medical College, New York, USA.

Journal of Medical Ethics
|February 6, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A future role for the pulmonary artery catheter?

Current opinion in anaesthesiology·2006
Same author

Forensic web watch.

Journal of clinical forensic medicine·2004
Same author

Forensic web watch.

Journal of clinical forensic medicine·2004
Same author

Metastasis in pleural mesothelioma. Immunohistochemical markers for disseminated disease.

Histopathology·2004
Same author

Offline telepathology diagnosis of colorectal polyps: a study of interobserver agreement and comparison with glass slide diagnoses.

Journal of clinical pathology·2002
Same author

Clinical advisory: phenylephrine advisory panel report.

International journal of pediatric otorhinolaryngology·1998

Physician-researchers face dilemmas when patient symptoms could be drug side effects or new conditions. Blinding in research, while standard, can complicate clinical decision-making for patient care.

Area of Science:

  • Medical ethics
  • Clinical research methodology
  • Patient safety

Background:

  • Physicians often serve dual roles as clinicians and researchers.
  • Clinical trials frequently employ blinding to prevent bias.
  • Blinding requires researchers to withhold treatment information from participants and often clinicians.

Observation:

  • Mrs. W presented with new medical issues during a clinical trial.
  • Her physician was blinded to whether she was receiving the active drug or a placebo.
  • This created uncertainty regarding the cause of her symptoms.

Findings:

  • The physician's inability to ascertain the treatment allocation complicated diagnosis.
  • Differentiating between drug side effects and unrelated medical conditions became challenging.
Keywords:
Biomedical and Behavioral Research

Related Experiment Videos

  • The case highlights a potential conflict between research integrity and immediate patient care.

    • Implications:

    • Physician-researchers must navigate ethical considerations in blinded studies.
    • Protocols may need to address mechanisms for managing patient safety concerns in blinded trials.
    • The findings underscore the importance of balancing research objectives with the physician's duty to the patient.